Mitali Sarkar-Tyson
University of Western Australia, WA, Australia
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
Novel EptA inhibitors increase the susceptibility of N. gonorrhoeae to killing by innate immune defenses (93826)
9:40 AM
Van Chi Thai
Concurrent Session - Drug Targets and Vaccine Technologies
Capsule switching in an outbreak of clonal complex 11 Neisseria meningitidis in Western Australia is associated with recombination events and changes in virulence (93927)
9:40 AM
August Mikucki
Concurrent Session - Microbial Genomics & Bioinformatics
Investigating the role of SlyD in the virulence of Burkholderia pseudomallei (#109)
6:30 PM
Justine Bendo
Welcome Function & Poster Session I
Molecular characterisation of the putative de novo biotin biosynthesis genes bioA and bioB from Burkholderia pseudomallei (#141)
6:45 PM
Ashley Johnson
Welcome Function & Poster Session I
Testing the efficacy of novel macrophage infectivity potentiator protein inhibitors against Chlamydia trachomatis. (#123)
6:45 PM
Aleksandra W Debowski
Welcome Function & Poster Session I
Characterisation of the oxidative protein folding pathway in Neisseria gonorrhoeae (#133)
6:45 PM
Ethan Haese
Welcome Function & Poster Session I
Investigating Anthranilate Synthase in the Tryptophan Biosynthetic Pathway as a Target for Antimicrobial Drug Design against Burkholderia pseudomallei (#132)
7:45 PM
Sharita Ganeshan
Poster Session II & Trade Night
Investigating the role of Trigger Factor in Neisseria gonorrhoeae protein folding and homeostasis (#139)
6:45 PM
Joe Hooton
Welcome Function & Poster Session I
Deletion of the Burkholderia pseudomallei Class II Fructose 1,6-bisphosphate Aldolase (bpsl0798) has a Complex Pleiotropic Effect on both Metabolism and Virulence (#172)
7:45 PM
Clare L Moran
Poster Session II & Trade Night
Macrophages versus Burkholderia pseudomallei; tipping the balance following deletion of the folding protein PpiB. (94441)
11:00 AM
Nicole M Bzdyl
Concurrent Session - Host-Pathogen Interactions II